Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
---|---|---|---|---|---|---|---|---|---|
KROS | Keros Therapeutics, Inc. | Common Stock, Par Value $0.0001 Per Share | 11.8% | $56.3M | 4.79M | Pontifax Management 4 GP (2015) Ltd. | Apr 17, 2025 |
Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
---|